NextCure, Inc. (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
Address
9000 VIRGINIA MANOR ROAD, SUITE 200
BELTSVILLE, MD 20705
Founded
2015
Number of Employees
82
Website
http://www.nextcure.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)